Speaking Engagement Fireside Chat: Plausibility in European Patents – Where Has It Come From and Where Is It Going? May 12, 2022 9:25 AM - 9:45 AM Boston, MA
Speaking Engagement Chairman's Opening Address and Closing Remarks May 11, 2022 - May 12, 2022 Boston, MA
In the News With Billions at Stake, Supreme Court Dips Its Toes Into Biologic Drug Patents National Law Journal April 18, 2022
Bylined Articles Case Studies and Trends at the PTAB Involving 35 U.S.C. § 112 Sterne, Kessler, Goldstein & Fox March 7, 2022 David H. Holman, Ph.D. Eldora L. Ellison, Ph.D. Kirsten AK Weigel-Van Aken, M.D.
Speaking Engagement Patenting Antibodies in the Current Climate: Global Considerations and Strategies October 07, 2021 11:15 AM - 12:00 PM Virtual
Books and Chapters U.S. Biotechnology Patent Law, 2021 ed. Thomson Reuters September 8, 2021 Jorge A. Goldstein, Ph.D.
Press Release Managing IP Names Director Eldora L. Ellison, Ph.D. Among the “Top 250 Women in IP” Globally Sterne, Kessler, Goldstein & Fox July 9, 2021
Speaking Engagement Comprehensive and Effective IP Due Diligence June 17, 2021 12:20 PM - 1:10 PM Virtual
Bylined Articles Can Process Confer Structure to Distinguish the Art after Biogen v. EMD Serono? IPWatchdog May 3, 2021 Daniel K. Choo, Ph.D. Eric K. Steffe
In the News Skilled in the Art: Amgen and Sanofi Go Back to the Biotech Future at the Federal Circuit + Crowell Helps Vizzy Score Trademark Win Over Brizzy Law.com December 4, 2020
Speaking Engagement Protecting and Defending Inventions in the Microbiome Space: Challenges and Strategies December 01, 2020 9:15 AM - 9:45 AM Virtual
Webinar IP Strategies - Claiming New Methods of Use and New Formulations, and Licensing IP November 19, 2020 11:00 AM - 12:00 PM Virtual
Speaking Engagement Protecting and Defending Inventions in the Microbiome Space: Challenges and Strategies November 06, 2020 4:30 PM - 5:00 PM Virtual